Bridgette L. Jones

Bridgette L. Jones

Auto-generated profile, based on publicly available information

Bridgette L. Jones

University of Missouri Kansas City School of Medicine

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2019 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
MBMaggie Barnthouse
Maggie Barnthouse
BJBridgette L. Jones
Bridgette L. Jones

22 December 2010 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
BJB L Jones
B L Jones
GKG L Kearns
G L Kearns

23 September 2016 in Journal of Racial and Ethnic Health Disparities
Verified
Journal Article
Closed access
PDF file
BJBridgette L. Jones
Bridgette L. Jones
CVCarrie A. Vyhlidal
Carrie A. Vyhlidal
ABAndrea Bradley-Ewing
Andrea Bradley-Ewing
ASAshley Sherman
Ashley Sherman
KGKathy Goggin
Kathy Goggin

20 October 2022 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
BJBridgette L. Jones
Bridgette L. Jones
MCMelody C. Carter
Melody C. Carter
CDCarla M. Davis
Carla M. Davis
JWJulie Wang
Julie Wang

1 December 2015 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
SASara Anvari
Sara Anvari
CVCarrie A. Vyhlidal
Carrie A. Vyhlidal
HDHongying Dai
Hongying Dai
BJBridgette L. Jones
Bridgette L. Jones
Histamine is an important mediator in the pathogenesis of asthma. Variation in genes along the histamine production, response, and degradation pathway may be important in predicting response to antihistamines. We hypothesize that differences exist among single-nucleotide polymorphisms (SNPs) in genes of the histamine pathway between children with allergic versus nonallergic asthma. Children (7–18 yr of age; n = 202) with asthma were classified as allergic or nonallergic based on allergy skin testing. Genotyping was performed to detect known SNPs (n = 10) among genes (HDC, HNMT, ABP1, HRH1, and HRH4) within the histamine pathway. Chi square tests and Cochran-Armitage Trend were used to identify associations between genetic variants and allergic or nonallergic asthma. Significance was determined by P < 0.05 and false-positive report probability. After correction for race differences in genotype were observed, HRH1-17 TT (6% allergic versus 0% nonallergic; P = 0.04), HNMT-464 TT (41% allergic versus 29% nonallergic; P = 0.04), and HNMT-1639 TT (30% allergic versus 20% nonallergic; P = 0.04) were overrepresented among children with allergic asthma. Genotype differences specifically among the African-American children were also observed: HRH1-17 TT (13% allergic versus 0% nonallergic; P = 0.04) and HNMT-1639 TT (23% allergic versus 3% nonallergic; P = 0.03) genotypes were overrepresented among African-American children with allergic asthma. Our study suggests that genetic variation within the histamine pathway may be associated with an allergic versus nonallergic asthma phenotype. Further studies are needed to determine the functional significance of identified SNPs and their impact on antihistamine response in patients with asthma and allergic disease.

1 November 2019 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
BJBridgette L. Jones
Bridgette L. Jones
VSVincent Staggs
Vincent Staggs
BWBriana Woods-Jaeger
Briana Woods-Jaeger